Scienture (NASDAQ:SCNX) Trading Down 5.3% – Time to Sell?

Scienture Holdings, Inc. (NASDAQ:SCNX)’s stock price was down 5.3% on Friday . The stock traded as low as $0.36 and last traded at $0.36. Approximately 186,694 shares changed hands during mid-day trading, a decline of 34% from the average daily volume of 283,114 shares. The stock had previously closed at $0.38.

Analysts Set New Price Targets

Several equities analysts have weighed in on SCNX shares. Maxim Group started coverage on shares of Scienture in a report on Tuesday, February 24th. They issued a “buy” rating and a $1.50 target price on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Scienture in a report on Friday, March 27th. Finally, Wall Street Zen upgraded shares of Scienture to a “hold” rating in a report on Saturday, March 14th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Scienture currently has an average rating of “Hold” and an average target price of $1.50.

Scienture Trading Down 5.3%

The stock has a market capitalization of $14.63 million, a PE ratio of -0.14 and a beta of 3.29. The firm’s fifty day moving average is $0.38 and its 200-day moving average is $0.46.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.15. The company had revenue of $0.06 million during the quarter, compared to analysts’ expectations of $0.40 million.

Hedge Funds Weigh In On Scienture

A hedge fund recently bought a new stake in Scienture stock. Virtu Financial LLC acquired a new position in Scienture Holdings, Inc. (NASDAQ:SCNX) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned about 0.22% of Scienture as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 5.68% of the company’s stock.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.